Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators
The DOI matches its OpenAlex record.
Abstract
OBJECTIVE: To determine whether clinical selection for thrombolytic therapy for acute myocardial infarction results in a skewed population for subsequent adverse cardiovascular events. DESIGN: A comparison of the clinical features of the patients in the Survival and Ventricular Enlargement Study who either had or had not received thrombolytic therapy was conducted in both univariate and multiple logistic regression analyses. SETTING: Hospitalized patients experiencing acute myocardial infarction from 112 broadly representative, private, academic, and government hospitals in the United States and Canada. PATIENTS: All patients in the Survival and Ventricular Enlargement Study had had a recent myocardial infarction (less than 16 days) and had a left ventricular ejection fraction of 40% or less. INTERVENTION: Thrombolytic therapy was administered to 733 patients and was not given to 1498. MAIN OUTCOME MEASURES: The comparisons with respect to use of thrombolytic therapy were formulated after the completion of enrollment and indicated that the majority of patients did not receive thrombolytic therapy. RESULTS: The 1498 (67.1%) patients who did not receive thrombolytic therapy were at higher risk (older age, lower functional capacity, greater likelihood of a history of prior myocardial infarction, angina, diabetes, and hypertension) for subsequent cardiovascular events and, as anticipated, were more likely to have concomitant gastrointestinal and neurological diseases. A multiple logistic regression analysis indicated that older age, prior myocardial infarction, impaired functional status, employment status, diabetes, and neurological diseases were predictors of use of thrombolytic therapy. CONCLUSION: Although the Survival and Ventricular Enlargement Study population was selected for left ventricular dysfunction, the majority of patients who currently are judged clinically as unsuitable for thrombolytic therapy have a higher risk for adverse cardiovascular events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994) · The Lancet · doi:10.1016/s0140-6736(94)91161-4 · Cited by 2,744
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Mak, K.-H., Moliterno, D. J., Granger, C. B., Miller, D. P., White, H. D., Wilcox, R. G., Califf, R. M., & Topol, E. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00118-6 · Cited by 430
Miller, T. D., Christian, T. F., Hopfenspirger, M. R., Hodge, D. O., Gersh, B. J., & Gibbons, R. J. (1995) · Circulation · doi:10.1161/01.cir.92.3.334 · Cited by 393
Gender differences in advanced heart failure: insights from the BEST study
Ghali, J. K., Krause-Steinrauf, H. J., Adams, K. F., Khan, S. S., Rosenberg, Y. D., Yancy, C. W., Young, J. B., Goldman, S., Peberdy, M. A., & Lindenfeld, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.05.012 · Cited by 292
Malmberg, K., Ryden, L., Hamstent, A., Herlitz, J., Waldenstrom, A., Wedel, H., & on behalf of the DIGAMI study group (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015067 · Cited by 281
Management of coronary artery disease: therapeutic options in patients with diabetes
Hammoud, T., Tanguay, J.-F., & Bourassa, M. G. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00732-4 · Cited by 256
Aguilar, D., Solomon, S. D., Køber, L., Rouleau, J.-L., Skali, H., McMurray, J. J. V., Francis, G. S., Henis, M., O’Connor, C. M., Diaz, R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000142047.28024.f2 · Cited by 230
Self-citationDo the Results of Randomized Clinical Trials of Cardiovascular Drugs Influence Medical Practice?
Lamas, G. A., Pfeffer, M. A., Hamm, P., Wertheimer, J., Rouleau, J.-L., & Braunwald, E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270405 · Cited by 227
Self-citationKrumholz, H. M., Pasternak, R. C., Weinstein, M. C., Friesinger, G. C., Ridker, P. M., Tosteson, A. N. A., & Goldman, L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207023270102 · Cited by 206
McAlister, F. A., Taylor, L., Teo, K. K., Tsuyuki, R. T., Ackman, M. L., Yim, R., Montague, T. J., & The Clinical Quality Improvement Network (CQIN) Investigators (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb03837.x · Cited by 39
Metadata
- Authors
- Pfeffer, M. A.
- Venue
- JAMA
- Publisher
- American Medical Association
- Published
- 1991-07-24
- Volume
- 266
- Issue
- 4
- Pages
- 528-532
- ISSN
- 0002-9955 (ISSN-L)
- OpenAlex
- W4239407884
- Cited by
- 131
- References
- 0
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.